Investing
Emergent BioSolutions to lay off about 400 employees
© Reuters. FILE PHOTO: A nurse demonstrates the application of the NARCAN nasal spray medication at a outpatient treatment center in Indiana, Pennsylvania, U.S. August 9, 2017. Picture taken August 9, 2017. REUTERS/Adrees Latif/File Photo
(Reuters) – Emergent BioSolutions Inc said on Tuesday it plans to lay off about 400 employees across all businesses and cut back operations at some of its facilities.
The company added that it will reduce operations at its Bayview facility in Baltimore and the facility in Canton, Massachusetts.
Emergent will focus on its core products business of medical countermeasures and its overdose reversal nasal spray Narcan, the company said, adding that it will also do away with the chief operating officer role.
Read the full article here
-
Investing6 days ago
Hurricane Helene Hits Spruce Pine Mine, Quartz Used for Tech
-
Side Hustles7 days ago
5 Key Strategies for a Seamless Cloud Migration
-
Investing7 days ago
Israel stocks lower at close of trade; TA 35 down 0.23% By Investing.com
-
Side Hustles6 days ago
VP Exec’s Top Tips for Negotiating and Relationship-Building
-
Side Hustles7 days ago
Why the Future of Cybersecurity Marketing Relies on Trust
-
Passive Income7 days ago
Go Paperless with the PDF Reader Pro for $49.99
-
Investing6 days ago
Britain’s FTSE 100 rises as oil price jump boosts energy shares By Reuters
-
Side Hustles6 days ago
Why the Smallest Details Mean the Most in Marketing